

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | thrombin receptor signaling pathway (GO:0070493) | 5.73254666 |
| 2 | regulation of lipoprotein metabolic process (GO:0050746) | 5.01190989 |
| 3 | blood coagulation, intrinsic pathway (GO:0007597) | 4.96951634 |
| 4 | adenosine receptor signaling pathway (GO:0001973) | 4.62182872 |
| 5 | regulation of platelet aggregation (GO:0090330) | 4.57701244 |
| 6 | regulation of platelet activation (GO:0010543) | 4.27336650 |
| 7 | locomotory exploration behavior (GO:0035641) | 4.26744831 |
| 8 | positive regulation of endothelial cell differentiation (GO:0045603) | 4.25458873 |
| 9 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.25074045 |
| 10 | cellular potassium ion homeostasis (GO:0030007) | 4.16212734 |
| 11 | neutrophil activation involved in immune response (GO:0002283) | 4.13825030 |
| 12 | regulation of integrin-mediated signaling pathway (GO:2001044) | 4.05155381 |
| 13 | synaptic vesicle maturation (GO:0016188) | 4.03655054 |
| 14 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.03457520 |
| 15 | platelet aggregation (GO:0070527) | 3.99998349 |
| 16 | negative regulation of norepinephrine secretion (GO:0010700) | 3.93948183 |
| 17 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.87507221 |
| 18 | vocalization behavior (GO:0071625) | 3.86166800 |
| 19 | glutamate secretion (GO:0014047) | 3.84569991 |
| 20 | protein neddylation (GO:0045116) | 3.83919223 |
| 21 | plasma membrane fusion (GO:0045026) | 3.81747728 |
| 22 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.78606227 |
| 23 | sodium ion export (GO:0071436) | 3.75342967 |
| 24 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.73994980 |
| 25 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.65751049 |
| 26 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.63582918 |
| 27 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.62996378 |
| 28 | negative regulation of platelet activation (GO:0010544) | 3.61757552 |
| 29 | synaptic vesicle exocytosis (GO:0016079) | 3.61357498 |
| 30 | positive regulation of mast cell activation (GO:0033005) | 3.61321635 |
| 31 | layer formation in cerebral cortex (GO:0021819) | 3.60571287 |
| 32 | microtubule depolymerization (GO:0007019) | 3.58710855 |
| 33 | platelet degranulation (GO:0002576) | 3.58613705 |
| 34 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.56080100 |
| 35 | regulation of female receptivity (GO:0045924) | 3.54966959 |
| 36 | negative regulation of protein localization to cell surface (GO:2000009) | 3.51378114 |
| 37 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.45391413 |
| 38 | angiogenesis involved in wound healing (GO:0060055) | 3.44944997 |
| 39 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.42937056 |
| 40 | neuronal action potential propagation (GO:0019227) | 3.42241923 |
| 41 | negative regulation of heart contraction (GO:0045822) | 3.40235498 |
| 42 | relaxation of smooth muscle (GO:0044557) | 3.38790965 |
| 43 | positive regulation of blood coagulation (GO:0030194) | 3.37664983 |
| 44 | positive regulation of hemostasis (GO:1900048) | 3.37664983 |
| 45 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.36294221 |
| 46 | negative regulation of inclusion body assembly (GO:0090084) | 3.36228939 |
| 47 | proline transport (GO:0015824) | 3.31327358 |
| 48 | regulation of synapse structural plasticity (GO:0051823) | 3.29511868 |
| 49 | L-amino acid import (GO:0043092) | 3.28915769 |
| 50 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.18798011 |
| 51 | exploration behavior (GO:0035640) | 3.18341918 |
| 52 | protein localization to synapse (GO:0035418) | 3.18116212 |
| 53 | neurotransmitter secretion (GO:0007269) | 3.17962823 |
| 54 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.10477725 |
| 55 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.09533142 |
| 56 | positive regulation of coagulation (GO:0050820) | 3.09284023 |
| 57 | polyamine biosynthetic process (GO:0006596) | 3.06118828 |
| 58 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.05905283 |
| 59 | positive regulation of receptor recycling (GO:0001921) | 3.05884421 |
| 60 | platelet activation (GO:0030168) | 3.05270982 |
| 61 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.04105513 |
| 62 | negative regulation of heart rate (GO:0010459) | 3.02819098 |
| 63 | regulation of synaptic vesicle transport (GO:1902803) | 3.00511790 |
| 64 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.97856252 |
| 65 | cerebellar granule cell differentiation (GO:0021707) | 2.97152860 |
| 66 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.96619137 |
| 67 | microtubule polymerization or depolymerization (GO:0031109) | 2.95594165 |
| 68 | dendrite morphogenesis (GO:0048813) | 2.95436901 |
| 69 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.93937515 |
| 70 | fibrinolysis (GO:0042730) | 2.93422140 |
| 71 | cell communication by electrical coupling (GO:0010644) | 2.93143045 |
| 72 | female mating behavior (GO:0060180) | 2.92406874 |
| 73 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 2.91942616 |
| 74 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.88953224 |
| 75 | regulation of endothelial cell differentiation (GO:0045601) | 2.88157792 |
| 76 | regulation of homotypic cell-cell adhesion (GO:0034110) | 2.87748987 |
| 77 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.85109516 |
| 78 | lipoxygenase pathway (GO:0019372) | 2.85106306 |
| 79 | termination of signal transduction (GO:0023021) | 2.85071769 |
| 80 | potassium ion import (GO:0010107) | 2.84758273 |
| 81 | beta-amyloid metabolic process (GO:0050435) | 2.83832065 |
| 82 | cellular sodium ion homeostasis (GO:0006883) | 2.82325153 |
| 83 | neuron cell-cell adhesion (GO:0007158) | 2.82180344 |
| 84 | gamma-aminobutyric acid transport (GO:0015812) | 2.81791212 |
| 85 | amino acid import (GO:0043090) | 2.80245281 |
| 86 | fatty acid elongation (GO:0030497) | 2.80232913 |
| 87 | potassium ion homeostasis (GO:0055075) | 2.77719066 |
| 88 | dendritic spine morphogenesis (GO:0060997) | 2.77630311 |
| 89 | glutamate receptor signaling pathway (GO:0007215) | 2.77452053 |
| 90 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.77232798 |
| 91 | regulation of blood coagulation (GO:0030193) | 2.76660508 |
| 92 | regulation of hemostasis (GO:1900046) | 2.76660508 |
| 93 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.75795153 |
| 94 | homotypic cell-cell adhesion (GO:0034109) | 2.74853675 |
| 95 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.74391734 |
| 96 | positive regulation of muscle hypertrophy (GO:0014742) | 2.74159703 |
| 97 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.74159703 |
| 98 | response to auditory stimulus (GO:0010996) | 2.72543589 |
| 99 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.70704700 |
| 100 | positive regulation of vesicle fusion (GO:0031340) | 2.70680884 |
| 101 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.70619881 |
| 102 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.68878041 |
| 103 | synaptic transmission, glutamatergic (GO:0035249) | 2.67611785 |
| 104 | membrane depolarization during action potential (GO:0086010) | 2.67513366 |
| 105 | neurotransmitter transport (GO:0006836) | 2.67148384 |
| 106 | negative regulation of blood circulation (GO:1903523) | 2.65346696 |
| 107 | megakaryocyte development (GO:0035855) | 2.64446998 |
| 108 | activation of protein kinase A activity (GO:0034199) | 2.64276941 |
| 109 | protein targeting to Golgi (GO:0000042) | 2.63594533 |
| 110 | calcium ion-dependent exocytosis (GO:0017156) | 2.63578196 |
| 111 | regulation of sensory perception of pain (GO:0051930) | 2.63482449 |
| 112 | regulation of sensory perception (GO:0051931) | 2.63482449 |
| 113 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.63361225 |
| 114 | long-term memory (GO:0007616) | 2.62161630 |
| 115 | vesicle transport along microtubule (GO:0047496) | 2.61594649 |
| 116 | negative regulation of catecholamine secretion (GO:0033604) | 2.60739806 |
| 117 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.60552231 |
| 118 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.59620663 |
| 119 | positive regulation of systemic arterial blood pressure (GO:0003084) | 2.59552439 |
| 120 | axonal fasciculation (GO:0007413) | 2.59547964 |
| 121 | neuron-neuron synaptic transmission (GO:0007270) | 2.59362432 |
| 122 | mesodermal cell differentiation (GO:0048333) | 2.59051871 |
| 123 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.58766385 |
| 124 | relaxation of muscle (GO:0090075) | 2.58714331 |
| 125 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.58193296 |
| 126 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.58176123 |
| 127 | negative regulation of hemostasis (GO:1900047) | 2.58084386 |
| 128 | negative regulation of blood coagulation (GO:0030195) | 2.58084386 |
| 129 | multicellular organism reproduction (GO:0032504) | 2.57249655 |
| 130 | establishment of nucleus localization (GO:0040023) | 2.56948438 |
| 131 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.56529358 |
| 132 | L-phenylalanine catabolic process (GO:0006559) | 2.56529358 |
| 133 | C4-dicarboxylate transport (GO:0015740) | 2.56336100 |
| 134 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.56281837 |
| 135 | regulation of protein localization to cell surface (GO:2000008) | 2.55479902 |
| 136 | membrane repolarization (GO:0086009) | 2.55285324 |
| 137 | acrosome assembly (GO:0001675) | 2.55233520 |
| 138 | negative regulation of muscle contraction (GO:0045932) | 2.54892448 |
| 139 | neuron recognition (GO:0008038) | 2.52739272 |
| 140 | neuromuscular process controlling balance (GO:0050885) | 2.52494258 |
| 141 | establishment of protein localization to Golgi (GO:0072600) | 2.52078965 |
| 142 | regulation of synaptic plasticity (GO:0048167) | 2.51623038 |
| 143 | auditory behavior (GO:0031223) | 2.51579385 |
| 144 | negative regulation of response to food (GO:0032096) | 2.51457244 |
| 145 | negative regulation of appetite (GO:0032099) | 2.51457244 |
| 146 | long-term synaptic potentiation (GO:0060291) | 2.51258289 |
| 147 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.50817284 |
| 148 | neurotransmitter uptake (GO:0001504) | 2.50063614 |
| 149 | cell communication involved in cardiac conduction (GO:0086065) | 2.50012467 |
| 150 | postsynaptic membrane organization (GO:0001941) | 2.49116861 |
| 151 | regulation of coagulation (GO:0050818) | 2.48936174 |
| 152 | acrosome reaction (GO:0007340) | 2.48833609 |
| 153 | negative regulation of neural precursor cell proliferation (GO:2000178) | 2.47885756 |
| 154 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.47663667 |
| 155 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.47418023 |
| 156 | alanine transport (GO:0032328) | 2.47413236 |
| 157 | regulation of vesicle fusion (GO:0031338) | 2.46757851 |
| 158 | organic cation transport (GO:0015695) | 2.46379706 |
| 159 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.45943076 |
| 160 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.45079268 |
| 161 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.44769452 |
| 162 | regulation of norepinephrine secretion (GO:0014061) | 2.41492587 |
| 163 | regulation of postsynaptic membrane potential (GO:0060078) | 2.41348255 |
| 164 | positive regulation of wound healing (GO:0090303) | 2.40977853 |
| 165 | cell wall macromolecule metabolic process (GO:0044036) | 2.40269746 |
| 166 | cell wall macromolecule catabolic process (GO:0016998) | 2.40269746 |
| 167 | peripheral nervous system axon ensheathment (GO:0032292) | 2.40119748 |
| 168 | myelination in peripheral nervous system (GO:0022011) | 2.40119748 |
| 169 | platelet formation (GO:0030220) | 2.38826684 |
| 170 | positive regulation of synapse maturation (GO:0090129) | 2.38443754 |
| 171 | innervation (GO:0060384) | 2.37411336 |
| 172 | sperm motility (GO:0030317) | 2.36848203 |
| 173 | regulation of neurotransmitter levels (GO:0001505) | 2.36778589 |
| 174 | regulation of early endosome to late endosome transport (GO:2000641) | 2.35932865 |
| 175 | positive regulation of membrane potential (GO:0045838) | 2.35836626 |
| 176 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.35782310 |
| 177 | chemosensory behavior (GO:0007635) | 2.35591878 |
| 178 | neuronal ion channel clustering (GO:0045161) | 2.35163524 |
| 179 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.35111354 |
| 180 | glycine transport (GO:0015816) | 2.34265192 |
| 181 | transmission of nerve impulse (GO:0019226) | 2.33649461 |
| 182 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.32559774 |
| 183 | synapse assembly (GO:0007416) | 2.31537591 |
| 184 | regulation of neurotransmitter secretion (GO:0046928) | 2.31020699 |
| 185 | prepulse inhibition (GO:0060134) | 2.30848693 |
| 186 | synapse organization (GO:0050808) | 2.30740931 |
| 187 | positive regulation of potassium ion transport (GO:0043268) | 2.29580843 |
| 188 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.29098405 |
| 189 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.27822592 |
| 190 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.27546066 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.91790140 |
| 2 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 3.37243924 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.65164349 |
| 4 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.47766067 |
| 5 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.39969873 |
| 6 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.19112984 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.18247711 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.18247711 |
| 9 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.17947914 |
| 10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.11794216 |
| 11 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.11745075 |
| 12 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.10977117 |
| 13 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.07307509 |
| 14 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.04104260 |
| 15 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.02995611 |
| 16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.95279883 |
| 17 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.93980629 |
| 18 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.91455870 |
| 19 | GATA1_19941826_ChIP-Seq_K562_Human | 1.90112887 |
| 20 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.86545682 |
| 21 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.82985563 |
| 22 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78504715 |
| 23 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.77818401 |
| 24 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.77794135 |
| 25 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.77160641 |
| 26 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.75957561 |
| 27 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.72487522 |
| 28 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.71663589 |
| 29 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.71148190 |
| 30 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.70103440 |
| 31 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.69778777 |
| 32 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.69598575 |
| 33 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.64522588 |
| 34 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.63581963 |
| 35 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.61298897 |
| 36 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.56009911 |
| 37 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.53519898 |
| 38 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.48444690 |
| 39 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.47696135 |
| 40 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.47264364 |
| 41 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.45701611 |
| 42 | GATA1_22025678_ChIP-Seq_K562_Human | 1.36874826 |
| 43 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.36584344 |
| 44 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.35014943 |
| 45 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.34612748 |
| 46 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.34557761 |
| 47 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.33557737 |
| 48 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.32973913 |
| 49 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.32444976 |
| 50 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.32433244 |
| 51 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.29710355 |
| 52 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.28945990 |
| 53 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.28512947 |
| 54 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.28345511 |
| 55 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.27316488 |
| 56 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.27050908 |
| 57 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.26356131 |
| 58 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.26022446 |
| 59 | AR_25329375_ChIP-Seq_VCAP_Human | 1.25096334 |
| 60 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.24822576 |
| 61 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.24773397 |
| 62 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.24768721 |
| 63 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.24745869 |
| 64 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.21402988 |
| 65 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.20405835 |
| 66 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.19952614 |
| 67 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.19475253 |
| 68 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.18884801 |
| 69 | P300_19829295_ChIP-Seq_ESCs_Human | 1.18852446 |
| 70 | SPI1_23127762_ChIP-Seq_K562_Human | 1.18413707 |
| 71 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.18038885 |
| 72 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.16422510 |
| 73 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15751445 |
| 74 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.15473255 |
| 75 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.15248610 |
| 76 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.14611286 |
| 77 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.14256491 |
| 78 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.14188378 |
| 79 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.14155691 |
| 80 | GF1_26923725_Chip-Seq_HPCs_Mouse | 1.13564411 |
| 81 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.13211774 |
| 82 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.12722653 |
| 83 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.12704372 |
| 84 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.12323107 |
| 85 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.09258649 |
| 86 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09172809 |
| 87 | TP53_16413492_ChIP-PET_HCT116_Human | 1.08790410 |
| 88 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.08478753 |
| 89 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.07754068 |
| 90 | STAT3_23295773_ChIP-Seq_U87_Human | 1.07620053 |
| 91 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.07283125 |
| 92 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07283125 |
| 93 | AR_19668381_ChIP-Seq_PC3_Human | 1.06672828 |
| 94 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.06370906 |
| 95 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.04073292 |
| 96 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.03992346 |
| 97 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.03416354 |
| 98 | RXR_22108803_ChIP-Seq_LS180_Human | 1.02184219 |
| 99 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.02047557 |
| 100 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.01890810 |
| 101 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.01144161 |
| 102 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00022439 |
| 103 | TBL1_22424771_ChIP-Seq_293T_Human | 0.99428552 |
| 104 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.99096959 |
| 105 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.98839818 |
| 106 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.98669683 |
| 107 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.98495162 |
| 108 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.98176478 |
| 109 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.97891855 |
| 110 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.97099374 |
| 111 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.97020102 |
| 112 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.96648244 |
| 113 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.96527270 |
| 114 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.96036724 |
| 115 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.96009992 |
| 116 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95780210 |
| 117 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95738800 |
| 118 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.95301553 |
| 119 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94674816 |
| 120 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.94470354 |
| 121 | TCF4_23295773_ChIP-Seq_U87_Human | 0.94352426 |
| 122 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.93880428 |
| 123 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.93841770 |
| 124 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93497514 |
| 125 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.92354986 |
| 126 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.92185497 |
| 127 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.91462986 |
| 128 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.91026891 |
| 129 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.91026891 |
| 130 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.90721010 |
| 131 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.90714572 |
| 132 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.90714572 |
| 133 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.90668576 |
| 134 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.90363459 |
| 135 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.89758855 |
| 136 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.89539562 |
| 137 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.88974843 |
| 138 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.88968539 |
| 139 | GF1B_26923725_Chip-Seq_HPCs_Mouse | 0.88836423 |
| 140 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.88834831 |
| 141 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.87434324 |
| 142 | KDM2B_26808549_Chip-Seq_K562_Human | 0.87004894 |
| 143 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.86067288 |
| 144 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.86049050 |
| 145 | * KDM2B_26808549_Chip-Seq_REH_Human | 0.86027676 |
| 146 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.85931068 |
| 147 | * SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.85607909 |
| 148 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.85367231 |
| 149 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84899268 |
| 150 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.84220725 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005464_abnormal_platelet_physiology | 7.41235750 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.90643268 |
| 3 | MP0008004_abnormal_stomach_pH | 4.51297926 |
| 4 | MP0004510_myositis | 3.63048045 |
| 5 | MP0000465_gastrointestinal_hemorrhage | 3.31297326 |
| 6 | MP0004270_analgesia | 3.20150374 |
| 7 | MP0003635_abnormal_synaptic_transmissio | 3.05901090 |
| 8 | MP0004084_abnormal_cardiac_muscle | 2.87560191 |
| 9 | MP0009046_muscle_twitch | 2.69991050 |
| 10 | MP0009780_abnormal_chondrocyte_physiolo | 2.63053741 |
| 11 | MP0004858_abnormal_nervous_system | 2.59294726 |
| 12 | MP0002063_abnormal_learning/memory/cond | 2.48376691 |
| 13 | MP0001968_abnormal_touch/_nociception | 2.47259488 |
| 14 | MP0009745_abnormal_behavioral_response | 2.45338548 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.31757090 |
| 16 | MP0004036_abnormal_muscle_relaxation | 2.29372055 |
| 17 | MP0003880_abnormal_central_pattern | 2.28633910 |
| 18 | MP0002064_seizures | 2.28056668 |
| 19 | MP0005410_abnormal_fertilization | 2.26837093 |
| 20 | MP0004885_abnormal_endolymph | 2.15605220 |
| 21 | MP0004043_abnormal_pH_regulation | 2.14489537 |
| 22 | MP0003329_amyloid_beta_deposits | 2.09790831 |
| 23 | MP0001486_abnormal_startle_reflex | 2.06736302 |
| 24 | MP0003566_abnormal_cell_adhesion | 2.02909943 |
| 25 | MP0001984_abnormal_olfaction | 2.02898509 |
| 26 | MP0002572_abnormal_emotion/affect_behav | 2.02659032 |
| 27 | MP0003724_increased_susceptibility_to | 1.98116564 |
| 28 | MP0005670_abnormal_white_adipose | 1.95029148 |
| 29 | MP0002735_abnormal_chemical_nociception | 1.93649728 |
| 30 | MP0005409_darkened_coat_color | 1.87334978 |
| 31 | MP0002272_abnormal_nervous_system | 1.81417511 |
| 32 | MP0002736_abnormal_nociception_after | 1.79663067 |
| 33 | MP0001440_abnormal_grooming_behavior | 1.77584677 |
| 34 | MP0000230_abnormal_systemic_arterial | 1.74640194 |
| 35 | MP0002822_catalepsy | 1.68976903 |
| 36 | MP0000751_myopathy | 1.66639672 |
| 37 | MP0005167_abnormal_blood-brain_barrier | 1.64924160 |
| 38 | MP0008775_abnormal_heart_ventricle | 1.62246357 |
| 39 | MP0002733_abnormal_thermal_nociception | 1.62214052 |
| 40 | MP0008569_lethality_at_weaning | 1.62179411 |
| 41 | MP0002067_abnormal_sensory_capabilities | 1.58480704 |
| 42 | MP0010234_abnormal_vibrissa_follicle | 1.58167176 |
| 43 | MP0005623_abnormal_meninges_morphology | 1.56465993 |
| 44 | MP0001970_abnormal_pain_threshold | 1.53163033 |
| 45 | MP0001879_abnormal_lymphatic_vessel | 1.49591913 |
| 46 | MP0001501_abnormal_sleep_pattern | 1.49253356 |
| 47 | MP0003828_pulmonary_edema | 1.47083301 |
| 48 | MP0001299_abnormal_eye_distance/ | 1.46729998 |
| 49 | MP0000778_abnormal_nervous_system | 1.46086102 |
| 50 | MP0005083_abnormal_biliary_tract | 1.45319674 |
| 51 | MP0005423_abnormal_somatic_nervous | 1.44921950 |
| 52 | MP0003303_peritoneal_inflammation | 1.44485052 |
| 53 | MP0002909_abnormal_adrenal_gland | 1.42797485 |
| 54 | MP0001851_eye_inflammation | 1.42092155 |
| 55 | MP0000015_abnormal_ear_pigmentation | 1.40333205 |
| 56 | MP0001958_emphysema | 1.40170766 |
| 57 | MP0002557_abnormal_social/conspecific_i | 1.39852651 |
| 58 | MP0003879_abnormal_hair_cell | 1.36181726 |
| 59 | MP0003633_abnormal_nervous_system | 1.35666322 |
| 60 | MP0005377_hearing/vestibular/ear_phenot | 1.34498988 |
| 61 | MP0003878_abnormal_ear_physiology | 1.34498988 |
| 62 | MP0003638_abnormal_response/metabolism_ | 1.30674816 |
| 63 | MP0001765_abnormal_ion_homeostasis | 1.30323673 |
| 64 | MP0002184_abnormal_innervation | 1.30127246 |
| 65 | MP0005646_abnormal_pituitary_gland | 1.29634792 |
| 66 | MP0000343_altered_response_to | 1.28273875 |
| 67 | MP0004811_abnormal_neuron_physiology | 1.24799374 |
| 68 | MP0000569_abnormal_digit_pigmentation | 1.24210956 |
| 69 | MP0008874_decreased_physiological_sensi | 1.22779144 |
| 70 | MP0001177_atelectasis | 1.21295198 |
| 71 | MP0005171_absent_coat_pigmentation | 1.20867745 |
| 72 | MP0003634_abnormal_glial_cell | 1.20717047 |
| 73 | MP0003045_fibrosis | 1.18499245 |
| 74 | MP0002882_abnormal_neuron_morphology | 1.18344251 |
| 75 | MP0005551_abnormal_eye_electrophysiolog | 1.17338053 |
| 76 | MP0005386_behavior/neurological_phenoty | 1.15526439 |
| 77 | MP0004924_abnormal_behavior | 1.15526439 |
| 78 | MP0003631_nervous_system_phenotype | 1.15318790 |
| 79 | MP0010329_abnormal_lipoprotein_level | 1.14540371 |
| 80 | MP0010368_abnormal_lymphatic_system | 1.12480121 |
| 81 | MP0009384_cardiac_valve_regurgitation | 1.11499541 |
| 82 | MP0005666_abnormal_adipose_tissue | 1.11218882 |
| 83 | MP0005248_abnormal_Harderian_gland | 1.08843656 |
| 84 | MP0001756_abnormal_urination | 1.08641864 |
| 85 | MP0000955_abnormal_spinal_cord | 1.07720221 |
| 86 | MP0003300_gastrointestinal_ulcer | 1.06445547 |
| 87 | MP0000013_abnormal_adipose_tissue | 1.05033623 |
| 88 | MP0004233_abnormal_muscle_weight | 1.05014895 |
| 89 | MP0003690_abnormal_glial_cell | 1.03775009 |
| 90 | MP0000249_abnormal_blood_vessel | 1.03627953 |
| 91 | MP0004742_abnormal_vestibular_system | 1.03586267 |
| 92 | MP0002066_abnormal_motor_capabilities/c | 1.02742237 |
| 93 | MP0003091_abnormal_cell_migration | 1.02734817 |
| 94 | MP0005174_abnormal_tail_pigmentation | 1.02140926 |
| 95 | MP0000534_abnormal_ureter_morphology | 1.01186473 |
| 96 | MP0002796_impaired_skin_barrier | 0.98618075 |
| 97 | MP0003453_abnormal_keratinocyte_physiol | 0.98222336 |
| 98 | MP0002090_abnormal_vision | 0.97253815 |
| 99 | MP0003183_abnormal_peptide_metabolism | 0.95682328 |
| 100 | MP0008961_abnormal_basal_metabolism | 0.95391707 |
| 101 | MP0004019_abnormal_vitamin_homeostasis | 0.94810174 |
| 102 | MP0001502_abnormal_circadian_rhythm | 0.94283994 |
| 103 | MP0006276_abnormal_autonomic_nervous | 0.93676147 |
| 104 | MP0005023_abnormal_wound_healing | 0.92329069 |
| 105 | MP0003656_abnormal_erythrocyte_physiolo | 0.92037908 |
| 106 | MP0010386_abnormal_urinary_bladder | 0.91715535 |
| 107 | MP0003632_abnormal_nervous_system | 0.91540203 |
| 108 | MP0001485_abnormal_pinna_reflex | 0.89882835 |
| 109 | MP0000920_abnormal_myelination | 0.89469510 |
| 110 | MP0002972_abnormal_cardiac_muscle | 0.88094919 |
| 111 | MP0004947_skin_inflammation | 0.86591036 |
| 112 | MP0004381_abnormal_hair_follicle | 0.85494975 |
| 113 | MP0000604_amyloidosis | 0.84590773 |
| 114 | MP0005058_abnormal_lysosome_morphology | 0.84421797 |
| 115 | MP0008872_abnormal_physiological_respon | 0.83964910 |
| 116 | MP0004484_altered_response_of | 0.83948513 |
| 117 | MP0003698_abnormal_male_reproductive | 0.83476274 |
| 118 | MP0002229_neurodegeneration | 0.83193069 |
| 119 | MP0003283_abnormal_digestive_organ | 0.82299339 |
| 120 | MP0002234_abnormal_pharynx_morphology | 0.82273798 |
| 121 | MP0004215_abnormal_myocardial_fiber | 0.82105687 |
| 122 | MP0005535_abnormal_body_temperature | 0.82097762 |
| 123 | MP0002152_abnormal_brain_morphology | 0.81821973 |
| 124 | MP0005275_abnormal_skin_tensile | 0.81784016 |
| 125 | MP0003011_delayed_dark_adaptation | 0.80509484 |
| 126 | MP0001929_abnormal_gametogenesis | 0.79983781 |
| 127 | MP0001963_abnormal_hearing_physiology | 0.79458013 |
| 128 | MP0003718_maternal_effect | 0.79418061 |
| 129 | MP0002896_abnormal_bone_mineralization | 0.78926732 |
| 130 | MP0000747_muscle_weakness | 0.78004738 |
| 131 | MP0004272_abnormal_basement_membrane | 0.77474508 |
| 132 | MP0004145_abnormal_muscle_electrophysio | 0.77192763 |
| 133 | MP0002118_abnormal_lipid_homeostasis | 0.73557066 |
| 134 | MP0005620_abnormal_muscle_contractility | 0.72749418 |
| 135 | MP0006138_congestive_heart_failure | 0.72453137 |
| 136 | MP0005499_abnormal_olfactory_system | 0.70823647 |
| 137 | MP0005394_taste/olfaction_phenotype | 0.70823647 |
| 138 | MP0005187_abnormal_penis_morphology | 0.69719593 |
| 139 | MP0009053_abnormal_anal_canal | 0.69690881 |
| 140 | MP0002752_abnormal_somatic_nervous | 0.69469005 |
| 141 | MP0003075_altered_response_to | 0.68801066 |
| 142 | MP0010678_abnormal_skin_adnexa | 0.68406688 |
| 143 | MP0009697_abnormal_copulation | 0.65596348 |
| 144 | MP0004085_abnormal_heartbeat | 0.65032497 |
| 145 | MP0001905_abnormal_dopamine_level | 0.64830874 |
| 146 | MP0003136_yellow_coat_color | 0.64579689 |
| 147 | MP0005165_increased_susceptibility_to | 0.64063687 |
| 148 | MP0000579_abnormal_nail_morphology | 0.64052376 |
| 149 | MP0002089_abnormal_postnatal_growth/wei | 0.63381991 |
| 150 | MP0002998_abnormal_bone_remodeling | 0.62497052 |
| 151 | MP0000749_muscle_degeneration | 0.62166407 |
| 152 | MP0004130_abnormal_muscle_cell | 0.61781381 |
| 153 | MP0000631_abnormal_neuroendocrine_gland | 0.60612139 |
| 154 | MP0002168_other_aberrant_phenotype | 0.60256369 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased mean platelet volume (HP:0011877) | 9.27627969 |
| 2 | Prolonged bleeding time (HP:0003010) | 9.04224015 |
| 3 | Menorrhagia (HP:0000132) | 8.95383292 |
| 4 | Abnormal platelet volume (HP:0011876) | 8.60411490 |
| 5 | Petechiae (HP:0000967) | 7.70789898 |
| 6 | Purpura (HP:0000979) | 7.55620479 |
| 7 | Gingival bleeding (HP:0000225) | 6.45521911 |
| 8 | Epistaxis (HP:0000421) | 6.09501236 |
| 9 | Abnormal platelet function (HP:0011869) | 4.86744737 |
| 10 | Impaired platelet aggregation (HP:0003540) | 4.86744737 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 4.60677148 |
| 12 | Focal motor seizures (HP:0011153) | 4.47770171 |
| 13 | Action tremor (HP:0002345) | 4.07354486 |
| 14 | Poikilocytosis (HP:0004447) | 3.92281976 |
| 15 | Myokymia (HP:0002411) | 3.91788263 |
| 16 | Spontaneous hematomas (HP:0007420) | 3.82138819 |
| 17 | Acanthocytosis (HP:0001927) | 3.57208712 |
| 18 | Increased circulating renin level (HP:0000848) | 3.52984951 |
| 19 | Ulnar claw (HP:0001178) | 3.52703513 |
| 20 | Conjunctival telangiectasia (HP:0000524) | 3.45021474 |
| 21 | Focal seizures (HP:0007359) | 3.42272724 |
| 22 | Aplasia involving bones of the extremities (HP:0009825) | 3.34593914 |
| 23 | Aplasia involving bones of the upper limbs (HP:0009823) | 3.34593914 |
| 24 | Aplasia of the phalanges of the hand (HP:0009802) | 3.34593914 |
| 25 | Metabolic alkalosis (HP:0200114) | 3.30263502 |
| 26 | Abnormality of the common coagulation pathway (HP:0010990) | 3.29793497 |
| 27 | Insidious onset (HP:0003587) | 3.23535068 |
| 28 | Termporal pattern (HP:0011008) | 3.23535068 |
| 29 | Papillary thyroid carcinoma (HP:0002895) | 3.20726297 |
| 30 | Hypokalemic alkalosis (HP:0001949) | 3.09553471 |
| 31 | Absent/shortened dynein arms (HP:0200106) | 2.99872603 |
| 32 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.99872603 |
| 33 | Hypomagnesemia (HP:0002917) | 2.95698300 |
| 34 | Abnormal pupillary function (HP:0007686) | 2.90504684 |
| 35 | Abnormal auditory evoked potentials (HP:0006958) | 2.89415960 |
| 36 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.83431124 |
| 37 | Progressive cerebellar ataxia (HP:0002073) | 2.75188237 |
| 38 | Bruising susceptibility (HP:0000978) | 2.73814528 |
| 39 | Visual hallucinations (HP:0002367) | 2.73091191 |
| 40 | Epileptic encephalopathy (HP:0200134) | 2.72670815 |
| 41 | Polyuria (HP:0000103) | 2.68966594 |
| 42 | Abnormality of renal excretion (HP:0011036) | 2.63751291 |
| 43 | Megalencephaly (HP:0001355) | 2.62737979 |
| 44 | Hyperactive renin-angiotensin system (HP:0000841) | 2.60752515 |
| 45 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.60688704 |
| 46 | Abnormal urine output (HP:0012590) | 2.60061437 |
| 47 | Polydipsia (HP:0001959) | 2.59573794 |
| 48 | Abnormal drinking behavior (HP:0030082) | 2.59573794 |
| 49 | Dyschromatopsia (HP:0007641) | 2.58556290 |
| 50 | Fetal akinesia sequence (HP:0001989) | 2.53108808 |
| 51 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.48383943 |
| 52 | Upper limb muscle weakness (HP:0003484) | 2.43548399 |
| 53 | Neurofibrillary tangles (HP:0002185) | 2.38888890 |
| 54 | Joint hemorrhage (HP:0005261) | 2.38666463 |
| 55 | Dysdiadochokinesis (HP:0002075) | 2.35818335 |
| 56 | Abnormality of magnesium homeostasis (HP:0004921) | 2.35304765 |
| 57 | Supranuclear gaze palsy (HP:0000605) | 2.33888019 |
| 58 | Abnormal eating behavior (HP:0100738) | 2.31602304 |
| 59 | Absence seizures (HP:0002121) | 2.30337578 |
| 60 | Cerebral inclusion bodies (HP:0100314) | 2.29782284 |
| 61 | Male infertility (HP:0003251) | 2.28031264 |
| 62 | Gout (HP:0001997) | 2.26867685 |
| 63 | Spontaneous abortion (HP:0005268) | 2.26817060 |
| 64 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.24063761 |
| 65 | Atonic seizures (HP:0010819) | 2.23364644 |
| 66 | Hyperventilation (HP:0002883) | 2.23269655 |
| 67 | Generalized tonic-clonic seizures (HP:0002069) | 2.20593226 |
| 68 | Abnormality of chloride homeostasis (HP:0011422) | 2.18560725 |
| 69 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.16152323 |
| 70 | Truncal ataxia (HP:0002078) | 2.15523981 |
| 71 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.14554844 |
| 72 | Ankle clonus (HP:0011448) | 2.10800222 |
| 73 | Hyperaldosteronism (HP:0000859) | 2.10083348 |
| 74 | Postural instability (HP:0002172) | 2.09782470 |
| 75 | Febrile seizures (HP:0002373) | 2.06865347 |
| 76 | Dialeptic seizures (HP:0011146) | 2.02737389 |
| 77 | Resting tremor (HP:0002322) | 2.02432613 |
| 78 | Broad-based gait (HP:0002136) | 2.00176113 |
| 79 | Intention tremor (HP:0002080) | 1.98262843 |
| 80 | Decreased central vision (HP:0007663) | 1.96560223 |
| 81 | Urinary urgency (HP:0000012) | 1.96048226 |
| 82 | Tubular atrophy (HP:0000092) | 1.95346753 |
| 83 | Paralysis (HP:0003470) | 1.94748518 |
| 84 | Xanthomatosis (HP:0000991) | 1.93411264 |
| 85 | Onion bulb formation (HP:0003383) | 1.93010697 |
| 86 | Abnormality of renin-angiotensin system (HP:0000847) | 1.92791249 |
| 87 | Depression (HP:0000716) | 1.92140569 |
| 88 | Hyporeflexia of lower limbs (HP:0002600) | 1.91502706 |
| 89 | Generalized aminoaciduria (HP:0002909) | 1.89358210 |
| 90 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.88454451 |
| 91 | Increased density of long bones (HP:0006392) | 1.87329197 |
| 92 | Tubulointerstitial fibrosis (HP:0005576) | 1.86441135 |
| 93 | Hypoplasia of the iris (HP:0007676) | 1.86147618 |
| 94 | Hammertoe (HP:0001765) | 1.85426401 |
| 95 | Bronchomalacia (HP:0002780) | 1.85330120 |
| 96 | Gaze-evoked nystagmus (HP:0000640) | 1.84894218 |
| 97 | Menstrual irregularities (HP:0000858) | 1.83623448 |
| 98 | Papilledema (HP:0001085) | 1.81312095 |
| 99 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.81021056 |
| 100 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.81021056 |
| 101 | Leiomyosarcoma (HP:0100243) | 1.80509252 |
| 102 | Uterine leiomyosarcoma (HP:0002891) | 1.80509252 |
| 103 | Akinesia (HP:0002304) | 1.79168902 |
| 104 | Abnormal ciliary motility (HP:0012262) | 1.79034779 |
| 105 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.78434913 |
| 106 | Genetic anticipation (HP:0003743) | 1.78373247 |
| 107 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.78113870 |
| 108 | Choroideremia (HP:0001139) | 1.77925538 |
| 109 | Renal salt wasting (HP:0000127) | 1.77870614 |
| 110 | Mitral stenosis (HP:0001718) | 1.77674297 |
| 111 | Peripheral hypomyelination (HP:0007182) | 1.77582680 |
| 112 | Postural tremor (HP:0002174) | 1.77230198 |
| 113 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.76753443 |
| 114 | Hemiparesis (HP:0001269) | 1.76358577 |
| 115 | Potter facies (HP:0002009) | 1.75979507 |
| 116 | Facial shape deformation (HP:0011334) | 1.75979507 |
| 117 | Infertility (HP:0000789) | 1.75539100 |
| 118 | Steppage gait (HP:0003376) | 1.74644121 |
| 119 | Mutism (HP:0002300) | 1.74416982 |
| 120 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.74311395 |
| 121 | Abnormality of the fovea (HP:0000493) | 1.73579951 |
| 122 | Diplopia (HP:0000651) | 1.73423696 |
| 123 | Abnormality of binocular vision (HP:0011514) | 1.73423696 |
| 124 | Abnormality of lateral ventricle (HP:0030047) | 1.72405705 |
| 125 | Thyroid carcinoma (HP:0002890) | 1.70863167 |
| 126 | Excessive salivation (HP:0003781) | 1.70693365 |
| 127 | Drooling (HP:0002307) | 1.70693365 |
| 128 | Abnormal large intestine physiology (HP:0012700) | 1.70320539 |
| 129 | Spastic gait (HP:0002064) | 1.69735740 |
| 130 | Tetany (HP:0001281) | 1.69684627 |
| 131 | Blue irides (HP:0000635) | 1.68598619 |
| 132 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.68369936 |
| 133 | Dysmetria (HP:0001310) | 1.67376297 |
| 134 | Ventricular fibrillation (HP:0001663) | 1.67236743 |
| 135 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.66258445 |
| 136 | Overgrowth (HP:0001548) | 1.65620676 |
| 137 | Bundle branch block (HP:0011710) | 1.65378282 |
| 138 | Hyperkalemia (HP:0002153) | 1.65061058 |
| 139 | Neonatal short-limb short stature (HP:0008921) | 1.63824954 |
| 140 | Abnormality of potassium homeostasis (HP:0011042) | 1.63296152 |
| 141 | Adrenal overactivity (HP:0002717) | 1.63126064 |
| 142 | Increased CSF protein (HP:0002922) | 1.62893898 |
| 143 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.62195817 |
| 144 | Decreased motor nerve conduction velocity (HP:0003431) | 1.62058068 |
| 145 | Anxiety (HP:0000739) | 1.61607216 |
| 146 | Impaired vibratory sensation (HP:0002495) | 1.61593072 |
| 147 | Impaired social interactions (HP:0000735) | 1.60627311 |
| 148 | Abnormal social behavior (HP:0012433) | 1.60627311 |
| 149 | Atrophic scars (HP:0001075) | 1.60173532 |
| 150 | Obstructive sleep apnea (HP:0002870) | 1.59904920 |
| 151 | Foot dorsiflexor weakness (HP:0009027) | 1.59477445 |
| 152 | Portal hypertension (HP:0001409) | 1.58212029 |
| 153 | Bladder carcinoma (HP:0002862) | 1.58078406 |
| 154 | Bladder neoplasm (HP:0009725) | 1.58078406 |
| 155 | Hyperthyroidism (HP:0000836) | 1.57530287 |
| 156 | Scotoma (HP:0000575) | 1.55946344 |
| 157 | Hypophosphatemic rickets (HP:0004912) | 1.55777986 |
| 158 | Lower limb amyotrophy (HP:0007210) | 1.55287581 |
| 159 | Tinnitus (HP:0000360) | 1.53774442 |
| 160 | Joint swelling (HP:0001386) | 1.52958967 |
| 161 | Arterial thrombosis (HP:0004420) | 1.52754167 |
| 162 | Abnormality of the corticospinal tract (HP:0002492) | 1.52369621 |
| 163 | Bowel incontinence (HP:0002607) | 1.52292992 |
| 164 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.50880583 |
| 165 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.50727968 |
| 166 | Distal lower limb amyotrophy (HP:0008944) | 1.46342810 |
| 167 | Testicular neoplasm (HP:0010788) | 1.45748679 |
| 168 | Vertigo (HP:0002321) | 1.45242078 |
| 169 | Abnormality of sodium homeostasis (HP:0010931) | 1.44059478 |
| 170 | Myocardial infarction (HP:0001658) | 1.43852837 |
| 171 | Rickets (HP:0002748) | 1.42800160 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BMX | 3.27609311 |
| 2 | NTRK3 | 3.07884338 |
| 3 | EPHA4 | 3.07765968 |
| 4 | PRKD3 | 2.80215453 |
| 5 | MST4 | 2.73635668 |
| 6 | MAP3K9 | 2.72474682 |
| 7 | PIK3CG | 2.69986454 |
| 8 | MYLK | 2.67198960 |
| 9 | WNK4 | 2.54434660 |
| 10 | PDK3 | 2.50777130 |
| 11 | PDK4 | 2.50777130 |
| 12 | MARK1 | 2.35289828 |
| 13 | OXSR1 | 2.32464702 |
| 14 | EIF2AK1 | 2.23455544 |
| 15 | MINK1 | 2.12263973 |
| 16 | MAP3K4 | 2.10342218 |
| 17 | STK39 | 2.02735098 |
| 18 | TEC | 1.88576922 |
| 19 | PAK6 | 1.87112075 |
| 20 | STK38 | 1.84212478 |
| 21 | NTRK2 | 1.83975308 |
| 22 | LMTK2 | 1.83148665 |
| 23 | NTRK1 | 1.78643149 |
| 24 | WNK3 | 1.72735754 |
| 25 | STK3 | 1.68671832 |
| 26 | DAPK2 | 1.67352497 |
| 27 | MAP3K2 | 1.64279372 |
| 28 | BMPR2 | 1.61136198 |
| 29 | PDK2 | 1.57476971 |
| 30 | KSR2 | 1.47846199 |
| 31 | CAMKK1 | 1.47516113 |
| 32 | LATS2 | 1.47175221 |
| 33 | SYK | 1.43245504 |
| 34 | MAP2K7 | 1.39775323 |
| 35 | CASK | 1.37549823 |
| 36 | PHKG2 | 1.34261640 |
| 37 | PHKG1 | 1.34261640 |
| 38 | RIPK4 | 1.33907476 |
| 39 | BTK | 1.33400697 |
| 40 | TRIB3 | 1.31082499 |
| 41 | PAK3 | 1.28817478 |
| 42 | MAP2K4 | 1.27467245 |
| 43 | PTK2B | 1.25896865 |
| 44 | CDK5 | 1.24875259 |
| 45 | FER | 1.23490006 |
| 46 | PLK4 | 1.23472174 |
| 47 | FGR | 1.22936434 |
| 48 | TESK1 | 1.18261552 |
| 49 | PLK2 | 1.11894203 |
| 50 | LATS1 | 1.11841495 |
| 51 | RIPK1 | 1.11765371 |
| 52 | ZAP70 | 1.08514773 |
| 53 | WNK1 | 1.07562725 |
| 54 | SGK494 | 1.06909878 |
| 55 | SGK223 | 1.06909878 |
| 56 | CSF1R | 1.04353305 |
| 57 | TYRO3 | 1.03589721 |
| 58 | ARAF | 1.01763012 |
| 59 | KSR1 | 0.98530571 |
| 60 | INSRR | 0.96658179 |
| 61 | RET | 0.96441374 |
| 62 | NEK6 | 0.94754312 |
| 63 | DDR2 | 0.92895464 |
| 64 | PINK1 | 0.92199093 |
| 65 | FRK | 0.91689988 |
| 66 | HCK | 0.90603478 |
| 67 | MUSK | 0.88174970 |
| 68 | PRKCG | 0.88116661 |
| 69 | PKN1 | 0.87451414 |
| 70 | MAPK12 | 0.86704203 |
| 71 | PDGFRB | 0.85596882 |
| 72 | MAP3K12 | 0.83291269 |
| 73 | SGK3 | 0.83266946 |
| 74 | ILK | 0.80835146 |
| 75 | TAOK3 | 0.80574935 |
| 76 | GRK5 | 0.80222768 |
| 77 | SGK2 | 0.79925245 |
| 78 | FGFR2 | 0.79799040 |
| 79 | DMPK | 0.79711722 |
| 80 | CAMKK2 | 0.79424178 |
| 81 | PDPK1 | 0.78975010 |
| 82 | MARK2 | 0.78553246 |
| 83 | CAMK2A | 0.77960711 |
| 84 | ERBB2 | 0.76998804 |
| 85 | MET | 0.75366237 |
| 86 | GRK6 | 0.75107351 |
| 87 | MAP2K1 | 0.74597196 |
| 88 | FES | 0.74564239 |
| 89 | TNIK | 0.74115327 |
| 90 | MAP3K1 | 0.73683384 |
| 91 | CDK14 | 0.73108394 |
| 92 | CDK15 | 0.71274607 |
| 93 | PRKG1 | 0.70708205 |
| 94 | CDK18 | 0.70501768 |
| 95 | STK38L | 0.70070390 |
| 96 | PDK1 | 0.69487198 |
| 97 | STK11 | 0.69372293 |
| 98 | MOS | 0.68433157 |
| 99 | SGK1 | 0.68065570 |
| 100 | ROCK1 | 0.67383467 |
| 101 | SCYL2 | 0.67146114 |
| 102 | PAK1 | 0.64483238 |
| 103 | PTK2 | 0.64366055 |
| 104 | MAP3K3 | 0.63899933 |
| 105 | CSNK1G2 | 0.63449743 |
| 106 | PRKD1 | 0.63297985 |
| 107 | MAPK13 | 0.61355503 |
| 108 | MST1R | 0.60101579 |
| 109 | CAMK1G | 0.59701143 |
| 110 | TAOK1 | 0.58794428 |
| 111 | MAP3K7 | 0.57501860 |
| 112 | YES1 | 0.57360387 |
| 113 | CDK11A | 0.57307938 |
| 114 | BLK | 0.57235593 |
| 115 | PRKCE | 0.57091668 |
| 116 | ROCK2 | 0.55585814 |
| 117 | PNCK | 0.54927389 |
| 118 | PRKCH | 0.54874997 |
| 119 | MARK3 | 0.54419466 |
| 120 | NEK1 | 0.53923661 |
| 121 | TTN | 0.53018685 |
| 122 | TNK2 | 0.52783407 |
| 123 | PRPF4B | 0.52766713 |
| 124 | JAK2 | 0.52317918 |
| 125 | MAP3K5 | 0.51722368 |
| 126 | CDC42BPA | 0.49554047 |
| 127 | CAMK1 | 0.49128812 |
| 128 | DAPK1 | 0.48062160 |
| 129 | CDK19 | 0.47994679 |
| 130 | EPHB2 | 0.47333436 |
| 131 | ERBB3 | 0.45794679 |
| 132 | PDGFRA | 0.45387834 |
| 133 | RAF1 | 0.44480915 |
| 134 | ICK | 0.44273447 |
| 135 | DYRK1A | 0.43928909 |
| 136 | LIMK1 | 0.43691937 |
| 137 | PRKACG | 0.42922412 |
| 138 | NEK9 | 0.42089714 |
| 139 | PRKCZ | 0.41741167 |
| 140 | FYN | 0.41601755 |
| 141 | DAPK3 | 0.41526409 |
| 142 | STK24 | 0.39439243 |
| 143 | AKT3 | 0.39386777 |
| 144 | SIK2 | 0.38790282 |
| 145 | CAMK2G | 0.37942319 |
| 146 | CAMK2B | 0.37438155 |
| 147 | PRKCB | 0.36992562 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Platelet activation_Homo sapiens_hsa04611 | 3.59403141 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.56348658 |
| 3 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.37757744 |
| 4 | Nicotine addiction_Homo sapiens_hsa05033 | 2.30407645 |
| 5 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.28321594 |
| 6 | Salivary secretion_Homo sapiens_hsa04970 | 2.00506362 |
| 7 | Olfactory transduction_Homo sapiens_hsa04740 | 1.98847806 |
| 8 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.96965610 |
| 9 | Circadian entrainment_Homo sapiens_hsa04713 | 1.91988834 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 1.91084324 |
| 11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.84896529 |
| 12 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.84323480 |
| 13 | GABAergic synapse_Homo sapiens_hsa04727 | 1.79875971 |
| 14 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.79602579 |
| 15 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.73414822 |
| 16 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.71754110 |
| 17 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.70244379 |
| 18 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.68159809 |
| 19 | Morphine addiction_Homo sapiens_hsa05032 | 1.58411503 |
| 20 | Insulin secretion_Homo sapiens_hsa04911 | 1.51619772 |
| 21 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.48483579 |
| 22 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.48145695 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.45651669 |
| 24 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.41278496 |
| 25 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.39405229 |
| 26 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.39014483 |
| 27 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.38706669 |
| 28 | Taste transduction_Homo sapiens_hsa04742 | 1.26453349 |
| 29 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.24880799 |
| 30 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.24099878 |
| 31 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.21985681 |
| 32 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.18616296 |
| 33 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.17541775 |
| 34 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.16085589 |
| 35 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.16012137 |
| 36 | Long-term depression_Homo sapiens_hsa04730 | 1.15765354 |
| 37 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.15330263 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.12489740 |
| 39 | Mineral absorption_Homo sapiens_hsa04978 | 1.10882849 |
| 40 | Cocaine addiction_Homo sapiens_hsa05030 | 1.10504090 |
| 41 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.09365707 |
| 42 | Axon guidance_Homo sapiens_hsa04360 | 1.09057658 |
| 43 | Phototransduction_Homo sapiens_hsa04744 | 1.08113408 |
| 44 | Gap junction_Homo sapiens_hsa04540 | 1.07494518 |
| 45 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.06763451 |
| 46 | Glioma_Homo sapiens_hsa05214 | 1.04405223 |
| 47 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.03123682 |
| 48 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.02896432 |
| 49 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.02862014 |
| 50 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.02604111 |
| 51 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.01967022 |
| 52 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.01124578 |
| 53 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.00446308 |
| 54 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.96309461 |
| 55 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.95506001 |
| 56 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.93594496 |
| 57 | Histidine metabolism_Homo sapiens_hsa00340 | 0.93472798 |
| 58 | Bile secretion_Homo sapiens_hsa04976 | 0.93384730 |
| 59 | Melanogenesis_Homo sapiens_hsa04916 | 0.92451481 |
| 60 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.92303554 |
| 61 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.90359811 |
| 62 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.90219073 |
| 63 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.88569304 |
| 64 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.87645280 |
| 65 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.85909377 |
| 66 | Adherens junction_Homo sapiens_hsa04520 | 0.85779211 |
| 67 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.85495586 |
| 68 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.82286755 |
| 69 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.79825360 |
| 70 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.78697252 |
| 71 | Tight junction_Homo sapiens_hsa04530 | 0.78342302 |
| 72 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.78254776 |
| 73 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.78199569 |
| 74 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.77913299 |
| 75 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.75728530 |
| 76 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.75685542 |
| 77 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.75084087 |
| 78 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.73968594 |
| 79 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.72669510 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.71852979 |
| 81 | Retinol metabolism_Homo sapiens_hsa00830 | 0.70991371 |
| 82 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.70861783 |
| 83 | Alcoholism_Homo sapiens_hsa05034 | 0.70771171 |
| 84 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.70594868 |
| 85 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.69095763 |
| 86 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.68814851 |
| 87 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.68574360 |
| 88 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.68402419 |
| 89 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.66595360 |
| 90 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.66517088 |
| 91 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.65134340 |
| 92 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.64909098 |
| 93 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.63795524 |
| 94 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.63021842 |
| 95 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.62990614 |
| 96 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.62839289 |
| 97 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.61811185 |
| 98 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.61769601 |
| 99 | Amoebiasis_Homo sapiens_hsa05146 | 0.61561056 |
| 100 | ABC transporters_Homo sapiens_hsa02010 | 0.60161816 |
| 101 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.60045520 |
| 102 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59380645 |
| 103 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.58441155 |
| 104 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.57027910 |
| 105 | Endometrial cancer_Homo sapiens_hsa05213 | 0.56210255 |
| 106 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.56081003 |
| 107 | Focal adhesion_Homo sapiens_hsa04510 | 0.56050010 |
| 108 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.55878829 |
| 109 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.55499251 |
| 110 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.53737186 |
| 111 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.53225363 |
| 112 | Endocytosis_Homo sapiens_hsa04144 | 0.52083874 |
| 113 | Circadian rhythm_Homo sapiens_hsa04710 | 0.51624699 |
| 114 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51012050 |
| 115 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50905684 |
| 116 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.50264948 |
| 117 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.49936224 |
| 118 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.49871698 |
| 119 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.49589913 |
| 120 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.49178481 |
| 121 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.48973335 |
| 122 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48713029 |
| 123 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.48629186 |
| 124 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.48570571 |
| 125 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.48161866 |
| 126 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.47864699 |
| 127 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.46745401 |
| 128 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.45831591 |
| 129 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.44882170 |
| 130 | Melanoma_Homo sapiens_hsa05218 | 0.44588793 |
| 131 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.43924344 |
| 132 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.43300240 |
| 133 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.42595150 |
| 134 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.42552006 |
| 135 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.42241121 |

